ISPC iSpecimen Inc.
Healthcare$3.38-2.03%ClosedMarket Cap: $469,354
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.01
P/S
0.47
EV/EBITDA
0.21
DCF Value
$-44.39
FCF Yield
-1358.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-29.6%
Operating Margin
-961.4%
Net Margin
-1080.7%
ROE
-584.7%
ROA
-168.0%
ROIC
-924.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $156.0K | 45.9% | $-2.5M | $-2.3M | $— | — |
| Q4 null | $51.8K | -1056.9% | $-2.7M | $-5.0M | $— | — |
| FY null | $1.9M | 1.2% | $-9.0M | $-10.5M | $— | — |
| Q3 null | $106.6K | -91.9% | $-2.8M | $-2.8M | $— | — |
| Q2 null | $713.1K | 37.7% | $-1.8M | $-1.0M | $— | — |
| Q1 null | $1.1M | 37.8% | $-1.6M | $-1.7M | $— | — |
| Q4 null | $1.5M | 10.3% | $-5.8M | $-6.0M | $— | — |
| FY null | $9.3M | 42.9% | $-12.7M | $-12.5M | $— | — |
| Q3 null | $2.7M | 41.6% | $-1.7M | $-1.4M | $— | — |
| Q2 null | $2.9M | 50.3% | $-2.2M | $-2.1M | $— | — |
| Q1 null | $2.3M | 56.3% | $-3.0M | $-2.9M | $— | — |
| Q4 2023 | $2.6M | 44.6% | $-2.9M | $-3.1M | $-6.77 | — |